NYSE$TEVA
Teva Pharmaceutical Industries ADR · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
delivered a solid third quarter amidst foreign exchange headwinds
Teva Pharmaceutical Industries Ltd. reported a decrease of 8% in revenues compared to the third quarter of 2021, with revenues of $3,595 million. GAAP diluted EPS was $0.05 and Non-GAAP diluted EPS was $0.59. The company generated $543 million in cash flow from operating activities and $685 million in free cash flow.
- Revenues of $3.6 billion
- GAAP diluted EPS of $0.05
- Non-GAAP diluted EPS of $0.59
- Free cash flow of $685 million
Headline financials
Revenue & EPS history
Teva · Revenue · Quarterly
$3.6B
Revenue by segment
Teva · $1.54B total across 2 segments · Q3 2022
- Europe$1.07B—69.2%
- International Markets$475M—30.8%
Forward guidance
Teva revised its 2022 revenues outlook due to continued foreign exchange headwinds, but reaffirmed its operating income, Adjusted EBITDA, EPS, and free cash flow guidance.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+0.3%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+0.7%
Avg return
30 days after
51%
38 / 74 earnings
Positive
+27.1%
Q2 2022
Best reaction
-34.1%
Q2 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.1% | +11.9% | +11.7% | |
| Q4 2025 | +2.1% | +9.2% | +4.1% | |
| Q3 2025 | +20.4% | +18.6% | +39.1% | |
| Q2 2025 | +1.8% | -5.1% | +11.1% | |
| Q1 2025 | +8.9% | +11.4% | +10.2% | |
| Q4 2024 | -13.9% | -19.4% | -23.5% | |
| Q3 2024 | -6.8% | -7.5% | -7.7% | |
| Q2 2024 | +6.9% | +1.6% | +15.0% | |
| Q1 2024 | +14.7% | +21.0% | +20.6% | |
| Q4 2023 | +6.2% | +5.5% | +15.1% | |
| Q3 2023 | -3.0% | -2.4% | +8.6% | |
| Q2 2023 | +15.4% | +16.2% | +18.7% | |
| Q1 2023 | -9.8% | -11.3% | -19.5% | |
| Q4 2022 | -9.8% | -5.4% | -16.3% | |
| Q3 2022 | -3.3% | +3.7% | -1.1% | |
| Q2 2022 | +27.1% | +30.5% | +37.6% | |
| Q1 2022 | -2.3% | -8.1% | +11.6% | |
| Q4 2021 | +6.3% | +2.8% | -9.8% | |
| Q3 2021 | -7.0% | -1.7% | -9.6% | |
| Q2 2021 | +8.6% | +10.4% | +4.8% | |
| Q1 2021 | +2.6% | +4.2% | +0.3% | |
| Q4 2020 | -11.8% | -13.2% | -15.8% | |
| Q3 2020 | -1.0% | +4.5% | +11.6% | |
| Q2 2020 | +3.0% | +0.6% | -22.1% | |
| Q1 2020 | +7.7% | +9.0% | +22.5% | |
| Q4 2019 | +1.9% | -0.9% | -31.9% | |
| Q3 2019 | +14.8% | +18.6% | +22.5% | |
| Q2 2019 | +3.3% | -0.6% | -0.7% | |
| Q1 2019 | -0.3% | -4.1% | -43.2% | |
| Q4 2018 | -9.6% | -6.0% | -13.7% | |
| Q3 2018 | +13.1% | +15.6% | +7.8% | |
| Q2 2018 | -7.1% | -2.5% | -4.0% | |
| Q1 2018 | -4.1% | +1.6% | +17.7% | |
| Q4 2017 | -10.7% | -11.2% | -8.0% | |
| Q3 2017 | -18.7% | -16.6% | +8.8% | |
| Q2 2017 | -34.1% | -16.2% | -39.4% | |
| Q1 2017 | +1.7% | +1.3% | -3.6% | |
| Q4 2016 | +8.4% | +9.4% | +6.7% | |
| Q3 2016 | -7.2% | -6.0% | -10.5% | |
| Q2 2016 | +1.2% | -6.2% | -8.8% | |
| Q1 2016 | +5.2% | +1.7% | +10.8% | |
| Q4 2015 | -2.0% | — | — | |
| Q3 2015 | -5.1% | — | — | |
| Q2 2015 | -2.6% | — | — | |
| Q1 2015 | +0.1% | — | — | |
| Q3 2014 | +3.6% | — | — | |
| Q4 2014 | +2.0% | — | — | |
| Q2 2014 | -1.6% | — | — | |
| Q1 2014 | +2.0% | — | — | |
| Q4 2013 | -1.9% | — | — | |
| Q3 2013 | -1.5% | — | — | |
| Q2 2013 | -2.0% | — | — | |
| Q1 2013 | +1.0% | — | — | |
| Q4 2012 | +1.4% | — | — | |
| Q3 2012 | +2.6% | — | — | |
| Q2 2012 | -3.3% | — | — | |
| Q1 2012 | -5.4% | — | — | |
| Q4 2011 | +2.5% | — | — | |
| Q3 2011 | +7.0% | — | — | |
| Q2 2011 | +1.9% | — | — | |
| Q1 2011 | +5.6% | — | — | |
| Q4 2010 | +0.4% | — | — | |
| Q3 2010 | +0.3% | — | — | |
| Q2 2010 | -3.4% | — | — | |
| Q1 2010 | +0.9% | — | — | |
| Q4 2007 | +1.2% | — | — | |
| Q4 2009 | +1.2% | — | — | |
| Q3 2008 | -1.4% | — | — | |
| Q3 2009 | -1.4% | — | — | |
| Q2 2008 | -0.8% | — | — | |
| Q2 2009 | -0.8% | — | — | |
| Q1 2009 | -0.6% | — | — | |
| Q1 2008 | -0.6% | — | — | |
| Q4 2008 | -0.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro